Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4-Reference-Cited by-同舟云学术

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4

Published:2008-09 Issue:5 Volume:28 Page:574-580
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

ROSSIGNOL J. F.,KABIL S. M.,EL-GOHARY Y.,ELFERT A.,KEEFFE E. B.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2008.03781.x/fullpdf

Reference11 articles.

1. Diagnosis, management, and treatment of hepatitis C;Strader;Hepatology,2004

2. Hepatitis C genotype 4: what we know and what we don’t yet know;Kamal;Hepatology,2008

3. Nitazoxanide: a review of its use in the treatment of gastrointestinal infections;Anderson;Drugs,2007

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venezuelan equine encephalitis virus E1 protein interacts with PDIA6 and PDI inhibition reduces alphavirus production;Antiviral Research;2023-04

2. Therapeutic potential of salicylamide derivatives for combating viral infections;Medicinal Research Reviews;2023-03-10

3. Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis;Royal Society Open Science;2022-10

4. Synthesis, antiviral activity, preliminary pharmacokinetics and structural parameters of thiazolide amine salts;Future Medicinal Chemistry;2021-10

5. The Modulation of Cholesterol Metabolism Is Involved in the Antiviral Effect of Nitazoxanide;Infectious Disease Reports;2021-07-14